Detalhe da pesquisa
1.
Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: Results from the Phase II North American Multicenter Prospective Observational Trial.
Ann Surg
; 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38869440
2.
Oncologic outcomes following transanal total mesorectal excision: the United States experience.
Surg Endosc
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782828
3.
Discordance in Total Mesorectal Excision Specimen Grading in a Prospective Phase 2 Multicenter Rectal Cancer Trial: Are We Overestimating the Quality of Our Resections?
Ann Surg
; 278(3): 452-463, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450694
4.
Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results.
Surg Endosc
; 37(12): 9483-9508, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700015
5.
Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
Surg Endosc
; 34(9): 4101-4109, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31602515
6.
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(3): 219-229, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065058
7.
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
Oncogene
; 40(1): 140-151, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097857
8.
Laparoscopic resection for Crohn's disease: an experience with 335 cases.
Surg Endosc
; 23(10): 2380-4, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19263141
9.
High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma.
Sci Rep
; 8(1): 11570, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30068984
10.
[Diaphragmatic traumas. Personal experience]. / Traumi del diaframma. Esperienza personale.
Ann Ital Chir
; 77(5): 385-9, 2006.
Artigo
em Italiano
| MEDLINE | ID: mdl-17345985